Takashi Kei Kishimoto PhD

Prior to joining Selecta Biosciences in 2011, Dr Kishimoto was Vice President of Discovery Research at Momenta Pharmaceuticals, where he served in several leadership positions over the course of 5 years and led a multidisciplinary research group in advancing both novel and complex generic products for inflammation, oncology, and cardiovascular disease. Prior to working at Momenta, he served as Senior Director of Inflammation Research at Millennium Pharmaceuticals from 1999 to 2006, where he provided the scientific leadership for 4 programs in clinical development, and as an Associate Director of Research at Boehringer Ingelheim Pharmaceuticals. Dr Kishimoto has published over 50 peer‑reviewed articles in scientific journals, including Nature, Science, Cell, and The New England Journal of Medicine. Dr Kishimoto received his B.A. from New College of the University of South Florida and his PhD in Immunology from Harvard University.